pk 11195 has been researched along with Uterine Neoplasms in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takai, N | 1 |
| Kira, N | 1 |
| Ishii, T | 1 |
| Yoshida, T | 1 |
| Nishida, M | 1 |
| Nishida, Y | 1 |
| Nasu, K | 1 |
| Takano, M | 1 |
| Midori, H | 1 |
| Koga, S | 1 |
| Narahara, H | 1 |
1 other study available for pk 11195 and Uterine Neoplasms
| Article | Year |
|---|---|
A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 7; Cell Cycle; C | 2012 |